GUTS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Fractyl Health, Inc. Securities Lawsuit - Contact Levi & Korsinsky
Fractyl Health told investors in September 2025 that Revita-treated patients lost an additional 2.5% of body weight after stopping GLP-1 drugs; four months later the Company reported 4.5% weight regain, and GUTS shares closed at $0.46. NEW YORK , Oct. 14, 2026 /PRNewswire/ -- Levi &...
Covered in this story
Call it yourself
No calls on $GUTS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Fractyl Health →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.